Cargando…
Does use of nonsteroidal anti-inflammatory drugs increase patients’ clinical severity of COVID-19?
Autor principal: | de Oliveira, Henrique Souza Barros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Paulista de Medicina - APM
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615592/ https://www.ncbi.nlm.nih.gov/pubmed/34346964 http://dx.doi.org/10.1590/1516-3180.2021.0401.27052021 |
Ejemplares similares
-
Congenital nephrotic syndrome and nonsteroidal anti-inflammatory drugs
por: Aoun, B., et al.
Publicado: (2012) -
Nonsteroidal anti‐inflammatory drugs and pharyngitis
por: Mazzone, Stuart B, et al.
Publicado: (2022) -
Adverse reactions to nonsteroidal anti-inflammatory drugs and hypersensitivity to lipid transfer proteins
por: Nucera, Eleonora, et al.
Publicado: (2016) -
Nonsteroidal anti-inflammatory drugs exacerbated respiratory disease – the role of aspirin desensitisation in patients with nasal polyposis
por: Jenerowicz, Dorota, et al.
Publicado: (2021) -
Letter to Editor: Prophylactic Use of Nonsteroidal Anti-Inflammatory Drugs after Cataract Surgery and Corneal Melt
por: Shalchi, Zaid, et al.
Publicado: (2022)